Literature DB >> 11749948

Potential control of gastroesophageal reflux by local modulation of transient lower esophageal sphincter relaxations.

B T Massey1.   

Abstract

Transient lower esophageal sphincter relaxations (TLESRs) are neurally mediated abrupt reductions in lower esophageal sphincter (LES) pressure. TLESRs are not usually associated with deglutition or secondary peristalsis but are thought to be necessary for venting swallowed air from the stomach. Their central role in acid reflux, however, makes them a compelling therapeutic target for patients with gastroesophageal reflux disease. Pharmacologic approaches for reducing TLESR frequency are being studied, but theoretically more promising are endoscopic approaches that interfere with mechanoreceptor function. Further study into the mechanisms of action of these approaches is needed, as are controlled clinical trials to define the true utility of these techniques and identify patients who will receive the most benefit.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749948     DOI: 10.1016/s0002-9343(01)00829-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

Review 1.  Plasticity of Candida albicans Biofilms.

Authors:  David R Soll; Karla J Daniels
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

Review 2.  Endoscopic therapies of gastroesophageal reflux disease.

Authors:  Atif Iqbal; Vanessa Salinas; Charles-J Filipi
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

3.  Does laparoscopic antireflux surgery prevent the occurrence of transient lower esophageal sphincter relaxation?

Authors:  F Bahmeriz; S Dutta; C J Allen; C Gill Pottruff; M Anvari
Journal:  Surg Endosc       Date:  2003-05-06       Impact factor: 4.584

4.  Transient lower oesophageal sphincter relaxation in achalasia: everything but LOS relaxation.

Authors:  M A Kwiatek; J Post; J E Pandolfino; P J Kahrilas
Journal:  Neurogastroenterol Motil       Date:  2009-06-23       Impact factor: 3.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.